홈MCP워크벤치Skills
홈워크벤치알림마이페이지
llms.txt · MCP 가이드개인정보처리방침 · 이용약관 · 지원v1.8.3
  1. 홈
  2. /반응

5'-Phospho-2'-deoxyribocytidylylriboadenosine → (2R,3S,4R,5R)-2-((((((2R,3S,5R)-5-(4-amino-2-oxopyrimidin-1(2H)-yl)-2-((phosphonooxy)methyl)tetrahydrofuran-3-yl)oxy)(hydroxy)phosphoryl)oxy)methyl)-5-(6-amino-9H-purin-9-yl)-4-hydroxytetrahydrofuran-3-yl 2-(N-methylpent-4-enamido)acetate

HRID 1482382
인쇄

반응식

HRID 1482382 반응식
[P:1]([O:5][CH2:6][C@@H:7]1[C@@H:11]([O:12][P:13]([O:16][CH2:17][C@@H:18]2[C@@H:22]([OH:23])[C@@H:21]([OH:24])[C@H:20]([N:25]3[CH:33]=[N:32][C:31]4[C:26]3=[N:27][CH:28]=[N:29][C:30]=4[NH2:34])[O:19]2)([OH:15])=[O:14])[CH2:10][C@H:9]([N:35]2[CH:40]=[CH:39][C:38]([NH2:41])=[N:37][C:36]2=[O:42])[O:8]1)([OH:4])([OH:3])=[O:2].C([N+](CCCC)(CCCC)CCCC)CCC.P(OC[C@@H]1[C@@H](OP(OC[C@@H]2[C@@H](O)[C@@H](O)[C@H](N3C=NC4C3=NC=NC=4N)O2)(O)=O)C[C@H](N2C=CC(N)=NC2=O)O1)(O)(O)=O.[CH3:102][N:103]([CH2:110][C:111](OCC#N)=[O:112])[C:104](=[O:109])[CH2:105][CH2:106][CH:107]=[CH2:108]>O1CCCC1>[CH3:102][N:103]([CH2:110][C:111]([O:23][C@H:22]1[C@@H:21]([OH:24])[C@H:20]([N:25]2[CH:33]=[N:32][C:31]3[C:26]2=[N:27][CH:28]=[N:29][C:30]=3[NH2:34])[O:19][C@@H:18]1[CH2:17][O:16][P:13]([O:12][C@H:11]1[CH2:10][C@H:9]([N:35]2[CH:40]=[CH:39][C:38]([NH2:41])=[N:37][C:36]2=[O:42])[O:8][C@@H:7]1[CH2:6][O:5][P:1]([OH:4])([OH:3])=[O:2])([OH:15])=[O:14])=[O:112])[C:104](=[O:109])[CH2:105][CH2:106][CH:107]=[CH2:108]
참가 물질실험 절차후처리출처 및 근거반응 노트

참가 물질

5

반응물 3

HCID 1955115'-Phospho-2'-deoxyribocytidylylriboadenosineHCID 89668754cyanomethyl 2-(N-methylpent-4-enamido)acetateHCID 117735960((2R,3S,5R)-5-(4-Amino-2-oxopyrimidin-1(2H)-yl)-3-(((((2R,3S,4R,5R)-5-(6-amino-9H-purin-9-yl)-3,4-dihydroxytetrahydrofuran-2-yl)methoxy)(hydroxy)phosphoryl)oxy)tetrahydrofuran-2-yl)methyl dihydrogenphosphate tetrabutylammonium salt2회

생성물 1

HCID 89668667
(2R,3S,4R,5R)-2-((((((2R,3S,5R)-5-(4-amino-2-oxopyrimidin-1(2H)-yl)-2-((phosphonooxy)methyl)tetrahydrofuran-3-yl)oxy)(hydroxy)phosphoryl)oxy)methyl)-5-(6-amino-9H-purin-9-yl)-4-hydroxytetrahydrofuran-3-yl 2-(N-methylpent-4-enamido)acetate
수율 11.2%

시약·촉매·용매 1

HCID 8028Tetrahydrofuran용매

실험 절차

((2R,3S,5R)-5-(4-amino-2-oxopyrimidin-1(2H)-yl)-3-(((((2R,3S,4R,5R)-5-(6-amino-9H-purin-9-yl)-3,4-dihydroxytetrahydrofuran-2-yl)methoxy)(hydroxy)phosphoryl)oxy)tetrahydrofuran-2-yl)methyl dihydrogenphosphate (Compound 1h) (Compound 1h) (1.00 g, 1.57 mmol) was dissolved in buffer A (1 l), a solution of cyanomethyl 2-(N-methylpent-4-enamido)acetate (Compound SP704) (2.00 g, 9.51 mmol) in tetrahydrofuran (5 ml) was added and the mixture was stirred at room temperature for 30 minutes. The reaction solution was lyophilized, and the resulting residue was purified by reverse-phase silica gel column chromatography (0.5% aqueous trifluoroacetic acid solution/acetonitrile) to afford the title compound (Compound SP705) (139 mg, 11%).

후처리

  1. customthe resulting residue was purified by reverse-phase silica gel column chromatography (0.5% aqueous trifluoroacetic acid solution/acetonitrile)

출처 및 근거

ORD 기록
ord-709edf2996ed47e1b8fcc8991a5ec476
출처 데이터셋
uspto-grants-2016_08
DOI
10.6084/m9.figshare.5104873.v1
특허 번호
US09409952B2

반응 노트

이 페이지에서참가 물질실험 절차후처리출처 및 근거반응 노트